Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib Step-in Dosing in CML
NCT03205267Phase 2Unknown
- Sponsor
- University of Bonn
- Start
- Mar 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bosutinib in chronic myeloid leukemia (CML), sponsored by University of Bonn. Status: unknown.
02
Drugs
bosutinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT03205267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03205267.